Syed Rehman, MD
Internal Medicine · Richmond, VANPI 1205827615
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,875 of the $48,759 with a category attached, or 90.0%. Shire North American Group Inc accounts for 81.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $39,828 and has fallen 99.7% since, to $120 in 2025. Among internal medicine clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $761.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$40K
- Takeda Pharmaceuticals U.S.A., Inc.$8K
- Bard Peripheral Vascular, Inc.$923
- Medtronic$144
- AstraZeneca$30
- Cordis US CORP.$23
- plus $27 from 2 others
What the payments were for
- Speaking & faculty fees$43,87590%
- Travel & lodging$3,6487%
- Food & beverage$1,2363%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 36 | $39,811 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $7,802 |
| Bard Peripheral Vascular, Inc. | 9 | $923 |
| Medtronic | 1 | $144 |
| AstraZeneca | 2 | $30 |
| Cordis US CORP. | 1 | $23 |
| Fortis Surgical, LLC | 1 | $16 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CINRYZE$31,550
- HYQVIA$11,588
- CUVITRU$3,375
- Venclose Maven Catheter$694
- VenaSeal$144
How this compares
$48,759 in reported general payments places this provider in the 95th percentile of 2,724 internal medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 178 | $99,250 |
| XareltoRivaroxaban | 45 | $26,032 |
| EntrestoSacubitril/Valsartan | 23 | $14,605 |
| GemtesaVibegron | 14 | $6,676 |
| MyrbetriqMirabegron | 11 | $5,365 |
| Memantine Hcl ErMemantine Hcl | 17 | $4,647 |
| Atorvastatin Calcium | 242 | $3,738 |
| Rosuvastatin Calcium | 62 | $2,908 |
| Pantoprazole Sodium | 195 | $2,891 |
| Levothyroxine Sodium | 221 | $2,882 |
| Metoprolol Succinate | 164 | $2,761 |
| Bumetanide | 77 | $2,492 |
| Memantine Hcl | 73 | $2,446 |
| Amlodipine Besylate | 234 | $2,113 |
| Hydroxychloroquine Sulfate | 11 | $1,984 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $11 | $26,03245 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 internal medicine providers in Virginia.
Other internal medicine in Richmond
- Lawrence SchwartzRichmond$205K
- Wally SmithRichmond$177K
- Andrew PoklepovicRichmond$58K
- Leroy VaughanRichmond$55K
- Rachel WallerRichmond$55K
- Rafae ShaikhRichmond$41K
- Chau VoRichmond$24K
- Richard JacksonRichmond$17K
- Minh TranRichmond$16K
- Thokozeni LipatoRichmond$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.